Immunology News and Research

Latest Immunology News and Research

NIH awards $28M grant to establish new center for excellence to find treatment for Ebola virus

The National Institutes of Health has awarded a five-year, $28 million grant to establish a new center for excellence to find an antibody "cocktail" to fight two types of viruses that cause severe hemorrhagic fever, including the deadly Ebola virus. The project involves researchers from 15 institutions, including Kartik Chandran, Ph.D., and Jonathan Lai, Ph.D., at Albert Einstein College of Medicine of Yeshiva University. Einstein will receive approximately $4 million of the total grant.

21 Mar 2014

Investigational vaccine reduces number of tumors in mice with lung cancer

Researchers at UC Davis have found that the investigational cancer vaccine tecemotide, when administered with the chemotherapeutic cisplatin, boosted the immune response and reduced the number of tumors in mice with lung cancer.

20 Mar 2014

Researchers uncover new connection between allergy and cancer

While many are stocking up on allergy medicine in preparation for spring, a new study from researchers at Virginia Commonwealth University Massey Cancer Center has uncovered a new connection between allergy and cancer that could potentially lead to therapies involving common antihistamines.

20 Mar 2014

New improved mass spectrometry for analysis of chemical and biological materials

When it comes to analyzing cell components or body fluids or developing new medications, there is no way around mass spectrometry. Mass spectrometry is a highly sensitive method of measurement that has been used for many years for the analysis of chemical and biological materials.

19 Mar 2014

Computer analysis of various subtypes of asthma could eventually lead to improved therapy, says study

So many variables can contribute to shortness of breath that no person can keep them all straight. But a computer program, capable of tracking more than 100 clinical variables for almost 400 people, has shown it can identify various subtypes of asthma, which perhaps could lead to targeted, more effective treatments.

19 Mar 2014

Findings open way to identification of new cancer drugs to fight acute myeloid leukemia

The Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal (UdeM), in collaboration with the Maisonneuve-Rosemont Hospital's Quebec Leukemia Cell Bank, recently achieved a significant breakthrough thanks to the laboratory growth of leukemic stem cells, which will speed up the development of new cancer drugs.

18 Mar 2014

People who experience chronic sleep disturbance could face earlier onset of dementia, Alzheimer's

People who experience chronic sleep disturbance—either through their work, insomnia or other reasons—could face an earlier onset of dementia and Alzheimer's, according to a new pre-clinical study by researchers at Temple University.

18 Mar 2014

Study suggests effective therapeutics for IBD may hinge on targeting GM-CSF axis

The protein GM-CSF plays a critical role in maintaining immune tolerance in the gut, with defects in the protein increasing the susceptibility to inflammatory bowel diseases (IBD), according to a new mouse study by a team of researchers from the Icahn School of Medicine at Mount Sinai.

17 Mar 2014

Professor wins Paul Ehrlich and Ludwig Darmstaedter Prize for research on immune system

Michael Reth has won the Paul Ehrlich and Ludwig Darmstaedter Prize, awarded by the Paul Ehrlich Foundation, for his research on the immune system. For the first time since 1996, the prize goes to a scientist working in Germany.

17 Mar 2014

UC Davis MIND Institute named Intellectual and Developmental Disabilities Research Center

The UC Davis MIND Institute has been named an Intellectual and Developmental Disabilities Research Center, through a prestigious grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health - a distinction held by only a handful of neurodevelopmental centers nationwide committed to the diagnosis, prevention, treatment and amelioration of developmental disorders such as autism, fragile X syndrome and Down syndrome.

14 Mar 2014

MD Anderson collaborates with MedImmune to develop therapies that unleash patients' immune systems to attack cancers

The University of Texas MD Anderson Cancer Center and MedImmune, the global biologics research and development arm of AstraZeneca, will collaborate through MD Anderson's Moon Shots Program to develop therapies that unleash patients' immune systems to attack their cancers.

14 Mar 2014

PD-L1 plays important role in pathogenesis of multiple sclerosis

Experimental allergic encephalomyelitis is a mouse model of human multiple sclerosis with similar pathology and pathogenesis. Th1 cells play an important role in the pathogenesis of experimental allergic encephalomyelitis.

14 Mar 2014

Australians it's time to consider a flu vaccination

Although it is still early in the season, NPS MedicineWise is joining other health experts in recommending that people at risk of complications of the flu (influenza) get vaccinated against the illness.

13 Mar 2014

Wake Forest Baptist Center provides tips to deal with springtime allergies

The return of spring marks the end of the cold and flu season, but the warmer weather and longer days present a different set of health issues.

13 Mar 2014

Two synergistic therapies allow solid tumors to act as their own cancer-fighting vaccine

Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute eradicated solid tumors in laboratory mice using a novel combination of two targeted agents. These two synergistic therapies stimulate an immune response, ultimately allowing solid tumors to act as their own cancer-fighting vaccine.

13 Mar 2014

Researchers to send 48 microbes to International Space Station

Microbes collected from Northern California and throughout the nation will soon blast into orbit for research and a microgravity growth competition on the International Space Station (ISS).

13 Mar 2014

Researchers seek 400 treatment-naïve colon participants to measure non-invasive blood test

Investigators with Baylor Research Institute, a research arm of Baylor Scott & White Health, have opened participation for a new clinical trial that could determine whether a certain blood test can detect colon cancer before it even develops.

12 Mar 2014

UCSF School of Medicine ranked fourth nationwide in research and primary care education

UC San Francisco's School of Medicine ranked fourth nationwide in both research and primary care education this year, according to a new survey conducted by U.S. News & World Report.

11 Mar 2014

Royal Free London NHS Foundation Trust selects OpenText to manage scanned legacy case-notes

OpenText, the global leader in Enterprise Information Management (EIM), announced today that it has been selected by the Royal Free London NHS Foundation Trust to manage its scanned legacy case-notes.

11 Mar 2014

Clinipace Worldwide closes merger with Choice Pharma

Clinipace Worldwide, a global digital contract research organization (dCRO), announced today the closing of its merger with Choice Pharma, a Pan-Asian contract research organization. Bringing these organizations together strengthens Clinipace Worldwide's operational and therapeutic expertise in Asia, a region in high demand by Clinipace's clients.

11 Mar 2014

Immunology News and Research

Latest Immunology News and Research

NIH awards $28M grant to establish new center for excellence to find treatment for Ebola virus

Investigational vaccine reduces number of tumors in mice with lung cancer

Researchers uncover new connection between allergy and cancer

New improved mass spectrometry for analysis of chemical and biological materials

Computer analysis of various subtypes of asthma could eventually lead to improved therapy, says study

Findings open way to identification of new cancer drugs to fight acute myeloid leukemia

People who experience chronic sleep disturbance could face earlier onset of dementia, Alzheimer's

Study suggests effective therapeutics for IBD may hinge on targeting GM-CSF axis

Professor wins Paul Ehrlich and Ludwig Darmstaedter Prize for research on immune system

UC Davis MIND Institute named Intellectual and Developmental Disabilities Research Center

MD Anderson collaborates with MedImmune to develop therapies that unleash patients' immune systems to attack cancers

PD-L1 plays important role in pathogenesis of multiple sclerosis

Australians it's time to consider a flu vaccination

Wake Forest Baptist Center provides tips to deal with springtime allergies

Two synergistic therapies allow solid tumors to act as their own cancer-fighting vaccine

Researchers to send 48 microbes to International Space Station

Researchers seek 400 treatment-naïve colon participants to measure non-invasive blood test

UCSF School of Medicine ranked fourth nationwide in research and primary care education

Royal Free London NHS Foundation Trust selects OpenText to manage scanned legacy case-notes

Clinipace Worldwide closes merger with Choice Pharma

eBook: Cell-based technologies in drug discovery and Immunotherapy eBook

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy